Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.


Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2019
Historique:
received: 05 07 2018
accepted: 16 09 2018
pubmed: 25 9 2018
medline: 18 12 2019
entrez: 25 9 2018
Statut: ppublish

Résumé

Pulmonary carcinoids (PCs) display the common features of all well-differentiated neuroendocrine neoplasms (NEN) and are classified as low- and intermediate-grade malignant tumours (i.e., typical and atypical carcinoid, respectively). There is a paucity of randomised studies dedicated to advanced PCs and management principles are drawn from the larger gastroenteropancreatic NEN experience. There is growing evidence that NEN anatomic subgroups have different biology and different responses to treatment and, therefore, should be investigated as separate entities in clinical trials. In this review, we discuss the existing evidence and limitations of tumour classification, diagnostics and staging, prognostication, and treatment in the setting of PC, with focus on unmet medical needs and directions for the future.

Identifiants

pubmed: 30248673
pii: 000493980
doi: 10.1159/000493980
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-17

Investigateurs

Detlef Bartsch (D)
Rudolf Arnold (R)
Eric Baudin (E)
Lisa Bodei (L)
Ivan Borbath (I)
Jaume Capdevila (J)
Martyn Caplin (M)
Jie Chen (J)
Frederico Costa (F)
Anne Couvelard (A)
Jaroslaw Ćwikła (J)
Philippa Davies (P)
Herder de (H)
Massimo Falconi (M)
Jenny Falkerby (J)
Nicola Fazio (N)
Diego Ferone (D)
Andrea Frilling (A)
Rocio Garcia-Carbonero (R)
Simona Glasberg (S)
Vera Gorbunova (V)
Ashley Grossman (A)
Dieter Hörsch (D)
Robert Jensen (R)
Gregory Kaltsas (G)
Günter Klöppel (G)
Ulrich Knigge (U)
Beata Kos-Kudła (B)
Guenter Krejs (G)
Eric Krenning (E)
Matthew Kulke (M)
Steven Lamberts (S)
van Nieveen (V)
Juan O'Connor (J)
Dermot O'Toole (D)
Ulrich-Frank Pape (UF)
Stefano Partelli (S)
Marianne Pavel (M)
Marc Peeters (M)
John Ramage (J)
Nicholas Reed (N)
Guido Rindi (G)
Anja Rinke (A)
Philippe Ruszniewski (P)
Halfdan Sorbye (H)
Anders Sundin (A)
Jean-Yves Scoazec (JY)
Babs Taal (B)
Janson Tiensuu (J)
Christos Toumpanakis (C)
Juan Valle (J)
Marie-Pierre Vullierme (MP)
Staffan Welin (S)
Bertram Wiedenmann (B)

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Eric Baudin (E)

Oncologie Endocrinienne et Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France.

Aimee R Hayes (AR)

Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdom.

Jean-Yves Scoazec (JY)

Department of Pathology, University of Lyon, Lyon, France.

Pier Luigi Filosso (PL)

Department of Thoracic Surgery, University of Torino, Torino, Italy.

Eric Lim (E)

Department of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom.

Gregory Kaltsas (G)

Department of Pathophysiology, Division of Endocrinology, National University of Athens, Athens, Greece.

Andrea Frilling (A)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Jie Chen (J)

Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Beata Kos-Kudła (B)

Slaska Akademia Medyczna Klinika Endokrynologii, Zabrze, Poland.

Vera Gorbunova (V)

FSBI "N.N Blokhin Russian Cancer Research Centre," Russian Academy of Medical Sciences, Moscow, Russian Federation.

Bertram Wiedenmann (B)

Department of Hepatology and Gastroenterology, Campus Charité Mitte and Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Els Nieveen van Dijkum (E)

Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.

Jaroslaw B Ćwikła (JB)

Department of Radiology, Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland.

Jenny Falkerby (J)

Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.

Juan W Valle (JW)

Department of Medical Oncology, The Christie NHS Foundation Trust, University of Manchester/Institute of Cancer Sciences, Manchester, United Kingdom.

Matthew H Kulke (MH)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Martyn E Caplin (ME)

Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdomm.caplin@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH